2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To Benefit

Results from 3 major testosterone trials are expected in 2023. Read more to see why I think AbbVie and ANI are best positioned to benefit from this.

Sunday, January 1, 2023 at 12:29 pm

Full Coverage